Jack­ie Fouse gets back in­to bio­phar­ma as ex­ec­u­tive chair­man of Der­ma­vant; Ex-GSK chief An­drew Wit­ty joins a biotech board

→ A lit­tle more than four months af­ter Jack­ie Fouse said she was “re­tir­ing” as pres­i­dent of Cel­gene, she’s back run­ning her own biotech as ex­ec­u­tive chair­man of Der­ma­vant, one of sev­er­al new “vants” that Roivant chief Vivek Ra­maswamy has kicked in­to play over the last three years.

→ Tony Wood, Pfiz­er’s se­nior vice pres­i­dent of med­i­c­i­nal sci­ences, has been wooed over to take a key R&D post­ing at the UK phar­ma gi­ant. And the move in­cludes a shift in as­sign­ments tied to a new ef­fort at GSK in­volv­ing the use of ar­ti­fi­cial in­tel­li­gence in drug de­vel­op­ment. John Bal­doni, who pre­vi­ous­ly led this ef­fort, is mov­ing to head up a new team fo­cused on “en­hanc­ing drug dis­cov­ery through the use of in sil­i­co tech­nol­o­gy — in­clud­ing ar­ti­fi­cial in­tel­li­gence, ma­chine learn­ing and deep learn­ing.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER